Safety: what we know, what we dont What clinical trial safety reviews suggest The clinical safety review literature reports several reassuring signals: No meaningful increase in IGF-1 in monitored long-term studies (jofem.org) No clear negative effect on carbohydrate metabolism in testing described (contrast with full hGH) (jofem.org) No clear immunogenicity signal (e.g., anti-AOD antibodies) in the subset assessed in those trials (jofem.org) The major limitation: long-term real-world certainty is thin The problem with many peptides is not that everything is dangerousits that the certainty level is often lower than patients assume
Working with this compound
Measure week 6 against the week-0 baseline
How long does it take to see results from AOD 9604
Although the 100 mg of niacinamide in this injection is relatively modest compared to gram doses used to treat cholesterol, diabetic patients should still have their blood sugar observed, as even moderate niacinamide supplementation could necessitate small adjustments in diabetes medications
The product should be kept in a refrigerator when not in use, and not left at room temperature for prolonged periods, except for drawing up a dose